IL66311A - Androstane derivatives,processes for their manufacture and pharmaceutical preparations containing them - Google Patents

Androstane derivatives,processes for their manufacture and pharmaceutical preparations containing them

Info

Publication number
IL66311A
IL66311A IL66311A IL6631182A IL66311A IL 66311 A IL66311 A IL 66311A IL 66311 A IL66311 A IL 66311A IL 6631182 A IL6631182 A IL 6631182A IL 66311 A IL66311 A IL 66311A
Authority
IL
Israel
Prior art keywords
manufacture
processes
pharmaceutical preparations
preparations containing
androstane derivatives
Prior art date
Application number
IL66311A
Other languages
English (en)
Other versions
IL66311A0 (en
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of IL66311A0 publication Critical patent/IL66311A0/xx
Publication of IL66311A publication Critical patent/IL66311A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J21/00Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005Ketals
    • C07J21/006Ketals at position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0033Androstane derivatives substituted in position 17 alfa and 17 beta
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J53/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002Carbocyclic rings fused
    • C07J53/0043 membered carbocyclic rings
    • C07J53/0053 membered carbocyclic rings in position 12
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J53/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002Carbocyclic rings fused
    • C07J53/0043 membered carbocyclic rings
    • C07J53/0083 membered carbocyclic rings in position 15/16
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/001Oxiranes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL66311A 1981-07-29 1982-07-14 Androstane derivatives,processes for their manufacture and pharmaceutical preparations containing them IL66311A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19813130644 DE3130644A1 (de) 1981-07-29 1981-07-29 Neue androstan-derivate, verfahren zu ihrer herstellung und pharmazeutische praeparate, die diese verbindungen enthalten

Publications (2)

Publication Number Publication Date
IL66311A0 IL66311A0 (en) 1982-11-30
IL66311A true IL66311A (en) 1986-03-31

Family

ID=6138450

Family Applications (1)

Application Number Title Priority Date Filing Date
IL66311A IL66311A (en) 1981-07-29 1982-07-14 Androstane derivatives,processes for their manufacture and pharmaceutical preparations containing them

Country Status (17)

Country Link
US (2) US4457925A (pt)
EP (1) EP0071153B1 (pt)
JP (1) JPS5849400A (pt)
AT (1) ATE22086T1 (pt)
AU (1) AU558412B2 (pt)
CA (1) CA1210754A (pt)
DE (2) DE3130644A1 (pt)
DK (1) DK164325B (pt)
ES (1) ES514492A0 (pt)
FI (1) FI78110C (pt)
GB (1) GB2104899B (pt)
GR (1) GR76872B (pt)
IE (1) IE53711B1 (pt)
IL (1) IL66311A (pt)
NO (1) NO159661C (pt)
PT (1) PT75334B (pt)
ZA (1) ZA825480B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3331824A1 (de) * 1983-09-01 1985-03-21 Schering AG, Berlin und Bergkamen, 1000 Berlin Verfahren zur herstellung von 17(alpha)-acyloxy-6-chlor-1(alpha),2(alpha)-methylen-3,20-dionen
DE3347126A1 (de) * 1983-12-22 1985-07-11 Schering AG, 1000 Berlin und 4709 Bergkamen 11ss-aryl-estradiene, deren herstellung und diese enthaltende pharmazeutische praeparate
US4720489A (en) * 1984-10-15 1988-01-19 Douglas Shander Hair growth modification with ornithine decarboxylase inhibitors
JPS61286185A (ja) * 1985-06-13 1986-12-16 Yoshizo Koishi 刻印装置
DE3824247A1 (de) * 1988-07-13 1990-01-18 Schering Ag Neue androstan-derivate
GB9021546D0 (en) * 1990-10-04 1990-11-21 Beecham Group Plc Novel composition
DE4102244A1 (de) * 1991-01-24 1992-07-30 Schering Ag 14,16ss-ethano-15ss, 16(pfeil hoch)1(pfeil hoch)-cyclo-14ss-estra-1,3,5(10)-triene
US6743419B1 (en) 1992-12-22 2004-06-01 The Gillette Company Method of reducing hair growth employing sulfhydryl active compounds
US5411991A (en) * 1992-12-22 1995-05-02 Shander; Douglas Method of reducing hair growth employing sulfhydryl active compounds
CA2522784C (en) * 2003-04-01 2012-06-19 Hollis-Eden Pharmaceuticals, Inc. Antiandrogens with marginal agonist activity and methods of use
US8084446B2 (en) * 2005-04-26 2011-12-27 Eric Marchewitz Use of DHEA derivatives for enhancing physical performance
US20130123523A1 (en) * 2011-11-10 2013-05-16 Klaus Nickisch Methods for the preparation of etonogestrel and desogestrel

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR7871M (pt) * 1968-11-13 1970-04-27
DE2644427A1 (de) * 1976-09-30 1978-04-06 Schering Ag 17 beta-hydroxy-17 alpha-(3-acyloxypropyl)-4.6-androstadien-3-one und deren salze
CH631462A5 (de) * 1976-03-05 1982-08-13 Schering Ag Verfahren zur herstellung von neuen steroiden der androstan- oder oestranreihe.
DE2722706A1 (de) * 1977-05-16 1978-12-07 Schering Ag 15.16-methylen-androsta-4.15-dien- 3-one und verfahren zu ihrer herstellung
ES469510A1 (es) * 1977-05-16 1978-12-01 Schering Ag Procedimiento para la preparacion de 17beta hidroxi-4-an- drosten-3-onas.

Also Published As

Publication number Publication date
IE821824L (en) 1983-01-29
JPS5849400A (ja) 1983-03-23
DE3273186D1 (en) 1986-10-16
DE3130644A1 (de) 1983-02-17
FI78110B (fi) 1989-02-28
US4457925A (en) 1984-07-03
GB2104899B (en) 1985-01-30
AU8643982A (en) 1984-10-18
PT75334A (de) 1982-08-01
NO159661C (no) 1989-01-25
EP0071153B1 (de) 1986-09-10
NO822596L (no) 1983-01-31
CA1210754A (en) 1986-09-02
EP0071153A1 (de) 1983-02-09
NO159661B (no) 1988-10-17
ATE22086T1 (de) 1986-09-15
ZA825480B (en) 1983-11-30
DK164325B (da) 1992-06-09
US4587235A (en) 1986-05-06
JPH033678B2 (pt) 1991-01-21
GR76872B (pt) 1984-09-04
ES8305003A1 (es) 1983-04-16
FI822658A0 (fi) 1982-07-29
ES514492A0 (es) 1983-04-16
IL66311A0 (en) 1982-11-30
FI822658L (fi) 1983-01-30
AU558412B2 (en) 1987-01-29
IE53711B1 (en) 1989-01-18
FI78110C (fi) 1989-06-12
PT75334B (de) 1984-07-31
DK327082A (da) 1983-01-30
GB2104899A (en) 1983-03-16

Similar Documents

Publication Publication Date Title
IL66311A0 (en) Androstane derivatives,processes for their manufacture and pharmaceutical preparations containing them
FI80888B (fi) Foerfarande foer framstaellning av terapeutiskt verkande steroida karboxylsyraestrar.
ES514267A0 (es) "un procedimiento para la preparacion de derivados de pirrolidina".
ES8505518A1 (es) Procedimiento para preparar derivados de aminoacidos
FR2443471A1 (fr) Derives du type thiazolidine de la progesterone utiles notamment comme precurseurs de medicaments antiacne et antiseborrhee
ATE16010T1 (de) Neue hydrocortison-derivate, ihre herstellung und verwendung.
GB8306412D0 (en) Crown ether compounds
ATE18228T1 (de) Neue thieno-thiazol-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
EP0520879A3 (pt)
IE791781L (en) 4, 5-methano-bufadienolide rhamnosides
ES526898A0 (es) Procedimiento para la preparacion de nuevas 7 -aciltio-1 ,2 -metilen-3-oxo-17 -pregn-4-en-21,17-carbolactonas
IL63747A0 (en) New cardenolide bis-digitoxosides,processes for the preparation thereof and pharmaceutical compositions containing them
SE8303410D0 (sv) Benzene derivatives, processes for their preparation and pharmaceutical compositions comprising them
IL67323A0 (en) New dehydrocardenolide derivatives,process for the preparation thereof and pharmaceutical preparations containing the same
JPS55160800A (en) Steroidal compound and its preparation